Advertisement Pharmaceutical Business review - Page 160 of 5217 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
July 30, 2024

FDA approves Alpha Cognition’s ZUNVEYL for Alzheimer’s treatment

The US Food and Drug Administration (FDA) has approved Alpha Cognition's oral therapy, ZUNVEYL, for the treatment of mild-to-moderate Alzheimer's disease.

Continue
The approval of the asset for Alzheimer's disease was based on comprehensive chemistry, manufacturing, and controls information. Credit: Colin Behrens from Pixabay.
July 9, 2024

Adicet Bio’s ADI-270 receives FDA Fast Track Designation for kidney cancer treatment

Adicet Bio is into developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases. Credit: PDPics from Pixabay.
July 26, 2024

Confo Therapeutics secures €60m funds to progress GPCR-modulating therapies

This funding will enable the advancement of programmes, including molecules aimed at GPR75 for treating obesity. Credit: Vidmir Raic from Pixabay.

Contracts

December 14, 2022

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Micrograph of psoriasis vulgaris. Credit: Jenny Giang, Marc A. J. Seelen, Martijn B. A. van Doorn, Robert Rissmann,Errol P. Prens and Jeffrey Damman/ commons.wikimedia.org.

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Harbour BioMed, Moderna partner on immunotherapies development

Kite, Refuge sign license deal for gene expression platform for blood cancers

Deals

Deals July 15, 2024

Merck enhances ophthalmology portfolio with EyeBio acquisition

Pharmaceutical Business Review

Biocon signs licensing and supply deal for diabetes drug in Brazil

Q32 Bio concludes merger deal with Homology Medicines

Zuellig Pharma acquires Cialis and Alimta brands from Lilly

Popular

  1. LEO Pharma obtains positive EMA CHMP opinion for eczema treatment
  2. Oisín secures funds to advance treatments for age-related ailments
  3. FDA grants RMAT designation to AffyImmune’s AIC100 for thyroid cancer
  4. Vividion Therapeutics to expand capabilities with new R&D centre in US
  5. Apollo Therapeutics and University of Oxford sign drug discovery partnership

PRESS RELEASES

Gerresheimer Remains on Track in First Half of 2024
Gerresheimer Remains on Track in First Half of 2024
RWS Joins Meta’s Open Loop Programme to Shape Future of AI Policy
RWS Joins Meta’s Open Loop Programme to Shape Future of AI Policy
RWS’s Linguistic AI Solution Evolve Wins Prestigious 2024 AI Breakthrough Award
RWS’s Linguistic AI Solution Evolve Wins Prestigious 2024 AI Breakthrough Award
Science-Based Targets Initiative Validates RWS’ Commitment to Reducing Carbon Emissions
Science-Based Targets Initiative Validates RWS’ Commitment to Reducing Carbon Emissions
Tosoh Bioscience and the University of Applied Sciences Mittelhessen Announce Partnership in Continuous Purification of Viruses and Viral Vectors
Tosoh Bioscience and the University of Applied Sciences Mittelhessen Announce Partnership in Continuous Purification of Viruses and Viral Vectors

Suppliers

Whitepapers

Saving Through Partnership and Innovation
Saving Through Partnership and Innovation
Case Study: Exploring Machine Translation in a Global Pharmacovigilance Programme
Case Study: Exploring Machine Translation in a Global Pharmacovigilance Programme
Wound Care – Selecting the Right Antiseptic for Your Formulation
Wound Care – Selecting the Right Antiseptic for Your Formulation